Join
Live feed
·
INSIDERFilingvia Quantisnow
Travere Therapeutics Inc. logo

CHIEF EXECUTIVE OFFICER Dube Eric M converted options into 22,500 shares and sold $988,875 worth of shares (22,500 units at $43.95) as part of a pre-agreed trading plan (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
TVTX· Travere Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track TVTX (Travere Therapeutics Inc.) and more on Quantisnow.

CHIEF EXECUTIVE OFFICER Dube Eric M converted options into 22,500 shares and sold $988,875 worth of shares (22,500 units at $43.95) as part of a pre-agreed trading plan (SEC Form 4) | Quantisnow